Superior Planning, LLC’s Immunome IMNM Stock Holding History

Superior Planning, LLC’s Portfolio IMNM Stock Details IMNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$22	Buy	+1	New	+$25	﹤0.01%	2127

Other funds holding IMNM

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Silverarc Capital Management Boston, Massachusetts $854M AUM 179.73% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Superior Planning, LLC's IMNM Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Immunome (IMNM) in Q3 2026: 1 share worth $22. The stake represents ﹤0.01% of the portfolio and ranks #2127 among its holdings.

106 funds tracked by Wall St. Rank hold IMNM as of Q3 2026.

Superior Planning, LLC held 1 share of Immunome worth $22 as of Q3 2026.
Immunome was a new Superior Planning, LLC position in Q3 2026.
Immunome made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #2127 holding.
106 funds tracked by Wall St. Rank held Immunome as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.